The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy Strickland, M., Quek, L. & Psaila, B., 7 Oct 2021, (E-pub ahead of print) In: British Journal of Haematology. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1111/bjh.17850 Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis Dillon, R., Ahearne, M. J., Quek, L., Potter, N., Jovanovic, J., Foot, N., Valganon, M., Jayne, S., Dennis, M., Raj, K., Tauro, S., Dyer, M. J. S., Russell, N., Solomon, E. & Grimwade, D., Aug 2021, In: Leukemia. 35, 8, p. 2407-2411 5 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41375-021-01150-3 British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes Killick, S. B., Wiseman, D. H., Quek, L., Cargo, C., Culligan, D., Enright, H., Green, S., Ingram, W., Jones, G. L., Kell, J., Krishnamurthy, P., Kulasekararaj, A., Mills, J., Mufti, G., Payne, E. M., Raghavan, M., Stanworth, S. J., Sternberg, A., Bowen, D. & Haematology, B. S. F., Jul 2021, In: British Journal of Haematology. 194, 2, p. 282-293 12 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1111/bjh.17621 Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA MacBeth, K. J., Chopra, V. S., Tang, L., Zheng, B., Avanzino, B., See, W. L., Schwickart, M., Figueroa, M. E., Quek, L. & DiMartino, J. F., Jun 2021, In: Experimental Hematology. 98, p. 47-52.e6 Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.exphem.2021.03.003 Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation Crump, N. T., Hadjinicolaou, A. V., Xia, M., Walsby-Tickle, J., Gileadi, U., Chen, J-L., Setshedi, M., Olsen, L. R., Lau, I-J., Godfrey, L., Quek, L., Yu, Z., Ballabio, E., Barnkob, M. B., Napolitani, G., Salio, M., Koohy, H., Kessler, B. M., Taylor, S., Vyas, P., & 3 othersMcCullagh, J. S. O., Milne, T. A. & Cerundolo, V., 11 May 2021, In: Cell Reports. 35, 6, p. 109101 1 p., 109101. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.celrep.2021.109101 A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings? Silveira, D. R. A., Coelho-Silva, J. L., Silva, W. F., Vallance, G., Pereira-Martins, D. A., Madeira, M. I. A., Figueredo-Pontes, L. L., Velloso, E. D. R. P., Simoes, B. P., Peniket, A., Danby, R., Rego, E. M., Vyas, P., Traina, F., Bendit, I., Quek, L. & Rocha, V., 29 Sep 2020, In: Leukemia and Lymphoma. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1080/10428194.2020.1827252 Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia Silveira, D. R. A., Quek, L., Santos, I. S., Corby, A., Coelho-Silva, J. L., Pereira-Martins, D. A., Vallance, G., Brown, B., Nardinelli, L., Silva, W. F., Velloso, E. D. R. P., Lucena-Araujo, A. R., Traina, F., Peniket, A., Vyas, P., Rego, E. M., Bendit, I. & Rocha, V., 26 May 2020, In: Blood Advances. 4, 10, p. 2339-2350 12 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1182/bloodadvances.2019001419 Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML). Dinardo, C. D., Schuh, A. C., Stein, E. M., Montesinos, P., Wei, A., De Botton, S., Zeidan, A. M., Fathi, A. T., Quek, L., Kantarjian, H. M., Frattini, M. G., Lersch, F., Gong, J., Franovic, A., Vyas, P. & Dohner, H., 20 May 2020, In: Journal of Clinical Oncology. 38, 15 Research output: Contribution to journal › Meeting Abstract › peer-review Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML Choe, S., Wang, H., DiNardo, C. D., Stein, E. M., de Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Watts, J. M., Pollyea, D. A., Fathi, A. T., Tallman, M. S., Kantarjian, H. M., Stone, R. M., Quek, L., Konteatis, Z., Dang, L., Nicolay, B., Nejad, P., Liu, G., & 9 othersZhang, V., Liu, H., Goldwasser, M., Liu, W., Marks, K., Bowden, C., Biller, S. A., Attar, E. C. & Wu, B., 12 May 2020, In: Blood Advances. 4, 9, p. 1894-1905 12 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1182/bloodadvances.2020001503 Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis Bezerra, M. F., Lima, A. S., Pique-Borras, M-R., Silveira, D. R., Coelho-Silva, J. L., Pereira-Martins, D. A., Weinhauser, I., Franca-Neto, P. L., Quek, L., Corby, A., Oliveira, M. M., Lima, M. M., de Assis, R. A., Campos, P. D. M., Duarte, B. K., Bendit, I., Rocha, V., Rego, E. M., Traina, F., Saad, S. T., & 3 othersBeltrao, E. I., Bezerra, M. A. & Lucena-Araujo, A. R., 12 Mar 2020, In: Blood. 135, 11, p. 870-875 6 p. Research output: Contribution to journal › Letter › peer-review. DOIs: https://doi.org/10.1182/blood.2019003339 View all publications